Serological Testing Market is anticipated to grow to around USD 8.7 billion by 2032

The global serological testing market size was worth around USD 4.8 billion in 2023 and is predicted to grow to around USD 8.7 billion by 2032, with a compound annual growth rate (CAGR) of roughly 6.8% between 2024 and 2032.

Serological testing is a laboratory method that studies blood serum to find antibodies, antigens, and other immune markers that show past or current infections, autoimmune conditions, or vaccine responses. New technologies include multiplex platforms that check several biomarkers at once, point-of-care devices that give fast results, and automated laboratory systems that improve speed and accuracy. Modern methods use highly sensitive assays, strict quality control steps, and digital reporting systems that give healthcare workers reliable diagnostic information for patient care. These advances provide doctors, public health groups, and research bodies with accurate tools, quicker results, and broader testing options for managing diseases and tracking outbreaks.

Browse the full “Serological Testing Market By Technology (ELISA, NAT, CLIA/CMIA, and Others), By Product (Instruments and Consumables & Reagents), By Application (Hepatitis, Coronavirus (COVID-19), Human Immunodeficiency Virus (HIV), Rotavirus infections, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Other End Users), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032”- Report at https://www.zionmarketresearch.com/report/serological-testing-market

The growth of the global serological testing industry is primarily driven by the rising incidence of infectious diseases and the growing demand for accurate diagnostic solutions.

Market Growth Factors

Several factors are propelling the expansion of the serological testing market.

• Infectious disease monitoring: Growing global concerns about emerging pathogens and disease outbreaks have increased demand for serological tests that can identify immune responses, track infection spread, and support public health surveillance programs.
• Chronic disease management: The growing number of autoimmune disorders and chronic illnesses requires regular serological testing to check disease progress, treatment results, and immune health for better patient care.
• Vaccine development support: Expanding vaccination programs and new vaccine research drive high demand for serological testing to measure immune responses, check antibody levels, and assess protection time in different population groups.

Restraints

• Technical complexity requirements: Serological testing needs special laboratory equipment, trained staff, and strict quality control, creating challenges for use in healthcare systems with fewer resources and in developing regions.
• Result interpretation challenges: Antibody test results are often hard to read because of cross-reactivity, infection timing, and individual immune responses, making expert medical knowledge necessary for accurate diagnosis.

Serological Testing Market: Report Scope

Market Segmentation

The serological testing market can be segmented by test type, technology platform, application, end-user, and region.

Based on test type, the serological testing market is categorized into enzyme-linked immunosorbent assays, chemiluminescent immunoassays, fluorescence immunoassays, radioimmunoassays, rapid diagnostic tests, and others. Enzyme-linked immunosorbent assays are expected to maintain market leadership during the forecast period due to their proven accuracy, cost-effectiveness, and widespread availability across laboratory settings for various diagnostic applications.

Based on the technology platform, the serological testing industry is divided into automated testing systems, semi-automated platforms, manual testing methods, point-of-care devices, and multiplex testing systems. Automated testing systems dominate the market due to their high throughput capabilities, consistent results, and reduced potential for human error in large-scale diagnostic operations.

Based on application, the market is classified into infectious disease testing, autoimmune disorder diagnosis, allergy testing, blood screening procedures, and vaccine response monitoring. Infectious disease testing leads the market as it encompasses a wide range of pathogens and represents the largest volume of serological tests performed in clinical laboratories worldwide.

Based on end-user, the serological testing market is segmented into hospitals and clinics, diagnostic laboratories, research institutions, blood banks, and home care settings. Diagnostic laboratories hold the largest market share due to their specialized testing capabilities, advanced equipment, and capacity to handle large testing volumes from multiple healthcare providers.

North America leads the global serological testing market because of its strong healthcare systems, big investments in research and development, and clear rules for diagnostic testing. The region benefits from high disease awareness, wide insurance coverage for diagnostic tests, and constant innovation in testing technologies. Rising focus on personalized medicine and preventive care is pushing market growth. The presence of major diagnostic firms and large laboratory networks has built strong market leadership in healthcare and research. Strong export abilities and global partnerships also support market growth. Increasing demand for rapid point-of-care testing is further boosting the region’s market dominance.

Key Market Players

Leading companies operating in the global serological testing market include:

• Serological Research Institute (SERI)
• Chembio Diagnostics Inc.
• Cellex
• Randox Laboratories Ltd
• Abbott
• Bio-Rad Laboratories Inc.
• BD
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics
• Quest Diagnostics Incorporated
• Abcam Plc
• F. Hoffmann-La Roche Ltd.
• ELITech Group
• Teleflex Incorporated
• Grifols S.A.
• Global Scientific Company
• Beckman Coulter Inc.
• BIOMEDOMICS INC.
• Creative Diagnostics

Recent Developments

• In August 2025, Eurofins CellTx partnered with Roche Diagnostics to adopt the Donor Elecsys Serology Solution for improved transplant donor screening and enhanced testing capacity.
• In January 2025, Roche received FDA clearance for a new, highly sensitive in-situ hybridization (ISH) serology-adjacent assay targeting B-cell lymphoma identification to aid diagnostic precision.

The global serological testing market is segmented as follows:

By Technology

• ELISA
• NAT
• CLIA/CMIA
• Others

By Product

• Instruments
• Consumables and Reagents

By Application

• Hepatitis
• Coronavirus (COVID-19)
• Human Immunodeficiency Virus (HIV)
• Rotavirus infections
• Others

By End User

• Diagnostic Laboratories
• Hospitals
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com